MAVRILIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2 DOUBLE-BLIND, PLACEBO CONTROLLED STUDY

被引：0
|
作者：
Burmester, G. [1 ]
Weinblatt, M. [2 ]
McInnes, I. [3 ]
Barbarash, O. [4 ]
Esfandieri, E. [5 ]
Sleeman, M. [5 ]
Godwood, A. [5 ]
Magrini, F. [5 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] SIH Kemerovo Reg Clin Hosp, Kemerovo, Russia
[5] Medimmune Ltd, Cambridge, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2061
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] Mavrilimumab (an Anti-GM-CSFRα Monoclonal Antibody) in Subjects with Rheumatoid Arthritis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
    Burmester, Gerd R.
    Weinblatt, Michael E.
    Barbarash, Olga
    Vatutin, Mykola
    Szombati, Istvan
    Stoilov, Rumen
    Matsievskaya, Galina
    Venalis, Algirdas
    Esfandiari, Ehsanollah
    Grove, Geraldine
    Saurigny, Didier
    Sleeman, Matthew A.
    Godwood, Alex
    Magrini, Fabio
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4044 - 4044
  • [2] NEFOPAM IN RHEUMATOID-ARTHRITIS - RESULTS OF A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY
    SWINSON, DR
    BOOTH, J
    BAKER, RD
    CLINICAL RHEUMATOLOGY, 1988, 7 (03) : 411 - 412
  • [3] FEVERFEW IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO CONTROLLED-STUDY
    PATTRICK, M
    HEPTINSTALL, S
    DOHERTY, M
    ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (07) : 547 - 549
  • [4] NONATHYMULIN IN RHEUMATOID-ARTHRITIS - 2 DOUBLE-BLIND, PLACEBO CONTROLLED TRIALS
    AMOR, B
    DOUGADOS, M
    MERY, C
    DARDENNE, M
    BACH, JF
    ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (07) : 549 - 554
  • [5] SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY
    Huizinga, T. W.
    Kivitz, A. J.
    Rell-Bakalarska, M.
    Fleischmann, R. M.
    Jasson, M.
    Radin, A. R.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 60
  • [6] Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study
    Genovese, Mark C.
    Kivitz, Alan J.
    Simon Campos, J. Abraham
    Rell-Bakalarska, Maria
    Fleischmann, Roy M.
    Jasson, Martine
    Radin, Allen R.
    Huang, Xiaohong
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4041 - 4042
  • [7] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [8] THYMULIN IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
    AMOR, B
    DOUGADOS, M
    MERY, C
    DEGERY, A
    SIMONLAVOINE, N
    DARDENNE, M
    BACH, JF
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 68 - 68
  • [9] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [10] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137
12345